cefuroxime has been researched along with Burns in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Burns: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alekseev, AA | 1 |
| Krutikov, MG | 1 |
| Smirnov, SV | 1 |
| Malakhov, SF | 1 |
| Filimonov, AA | 1 |
1 trial available for cefuroxime and Burns
| Article | Year |
|---|---|
[Clinical results of Fortum and Zinacef trial in Burn Centers of Russia].
Topics: Adolescent; Bacterial Infections; Burn Units; Burns; Ceftazidime; Cefuroxime; Cephalosporins; Drug A | 1996 |